Effects of evolving lipid-lowering drugs on carbohydrate metabolism

被引：2

作者：

Tsimihodimos, V. ^{[1
]}

Elisaf, M. ^{[1
]}

机构：

[1] Univ Ioannina, Sch Med, Dept Internal Med, Niarchou Ave, GR-45110 Ioannina, Greece

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2018年 / 137卷

关键词：

Antisense oligonucleotides; PCSK9; inhibitors; Apolipoprotein CIII inhibitors; CETP inhibitors; Lp(a); LOW-DENSITY-LIPOPROTEIN; OF-FUNCTION MUTATIONS; ALPHA/DELTA AGONIST GFT505; APOLIPOPROTEIN C-III; TARGETING APOLIPOPROTEIN(A); GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; DOUBLE-BLIND; BETA-CELLS; HIGH-RISK;

D O I：

10.1016/j.diabres.2017.12.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The understanding that statins reduce but not eliminate the cardiovascular risk associated with disturbed lipid metabolism and the existence of forms of dyslipidemia that are unresponsive or only partially responsive to statins have led to the development of many novel lipid-lowering drugs. Accumulating evidence suggests that the interplay between carbohydrate and lipid metabolism is bidirectional. Thus, any intervention that affects lipid metabolism has the potential to influence the homeostasis of glucose. In this review we summarize the available data on the effects of the evolving lipid-lowering drugs on carbohydrate metabolism. (C) 2017 Elsevier B.V. All rights reserved.

引用

页码：1 / 9

页数：9

共 50 条

[1] PSYCHOLOGICAL EFFECTS OF LIPID-LOWERING DRUGS
HOUSTON, BK
DUJOVNE, CA
BABYAK, MA
PSYCHOSOMATIC MEDICINE, 1994, 56 (02): : 165 - 165
[2] Effects of Lipid-Lowering Drugs on Adiponectin
Perelas, Apostolos
Tsoulkani, Anna
Perrea, Despina
CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (06) : 836 - 848
[3] The role of cellular lipid metabolism and lipid-lowering drugs in periodontitis
Kiarashi, Mohammad
Yasamineh, Saman
INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 152
[4] Lipid-Lowering Drugs
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1506): : 133 - 140
[5] Lipid-Lowering Drugs
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1659): : 145 - +
[6] Lipid-lowering drugs
K. Pahan
Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1165 - 1178
[7] LIPID-LOWERING DRUGS
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1980, 22 (16): : 65 - 66
[8] LIPID-LOWERING DRUGS
THOMPSON, GR
LANCET, 1988, 1 (8585): : 597 - 597
[9] Lipid-Lowering Drugs
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1565): : 17 - 24
[10] Lipid-lowering drugs
Andréjak, M
Caron, J
Libersa, C
Thery, C
THERAPIE, 2003, 58 (01): : 1 - 2

← 1 2 3 4 5 →